Patients affected by the familial Li-Fraumeni syndrome (LFS) are characterized by germline mutations in the TP53 gene that predispose them to different types of tumors, such as breast cancer, soft tissue and bone sarcoma, brain cancer and adrenocortical carcinoma (ACC) [89,90]. The gene discussed is TP53; the disease is breast carcinoma.